Chwilio Deddfwriaeth

Chwiliad Uwch

Commission Regulation (EU) No 722/2012Dangos y teitl llawn

Commission Regulation (EU) No 722/2012 of 8 August 2012 concerning particular requirements as regards the requirements laid down in Council Directives 90/385/EEC and 93/42/EEC with respect to active implantable medical devices and medical devices manufactured utilising tissues of animal origin (Text with EEA relevance)

Help about what version

Pa Fersiwn

Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

Mae hon yn eitem o ddeddfwriaeth sy’n deillio o’r UE

Mae unrhyw newidiadau sydd wedi cael eu gwneud yn barod gan y tîm yn ymddangos yn y cynnwys a chyfeirir atynt gydag anodiadau.Ar ôl y diwrnod ymadael bydd tair fersiwn o’r ddeddfwriaeth yma i’w gwirio at ddibenion gwahanol. Y fersiwn legislation.gov.uk yw’r fersiwn sy’n weithredol yn y Deyrnas Unedig. Y Fersiwn UE sydd ar EUR-lex ar hyn o bryd yw’r fersiwn sy’n weithredol yn yr UE h.y. efallai y bydd arnoch angen y fersiwn hon os byddwch yn gweithredu busnes yn yr UE. EUR-Lex Y fersiwn yn yr archif ar y we yw’r fersiwn swyddogol o’r ddeddfwriaeth fel yr oedd ar y diwrnod ymadael cyn cael ei chyhoeddi ar legislation.gov.uk ac unrhyw newidiadau ac effeithiau a weithredwyd yn y Deyrnas Unedig wedyn. Mae’r archif ar y we hefyd yn cynnwys cyfraith achos a ffurfiau mewn ieithoedd eraill o EUR-Lex. The EU Exit Web Archive legislation_originated_from_EU_p3

Changes to legislation:

Commission Regulation (EU) No 722/2012 is up to date with all changes known to be in force on or before 12 October 2024. There are changes that may be brought into force at a future date. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the affected provisions when you open the content using the Table of Contents below.

View outstanding changes

Changes and effects yet to be applied to :

  • Regulation applied by S.I. 2002/618, reg. 4K(2)(4) (as inserted) by S.I. 2019/791 reg. 3(7) (This amendment not applied to legislation.gov.uk. The affecting text in reg. 3(7) is omitted (31.12.2020 immediately before IP completion day) by virtue of S.I. 2020/1478, reg. 1(3), Sch. 2 para. 9(h))
  • Regulation applied by S.I. 2002/618, reg. 4K(3) (as inserted) by S.I. 2019/791 reg. 3(7) (This amendment not applied to legislation.gov.uk. The affecting text in reg. 3(7) is omitted (31.12.2020 immediately before IP completion day) by virtue of S.I. 2020/1478, reg. 1(3), Sch. 2 para. 9(h))
  • Regulation revoked by S.I. 2002/618, reg. 4K (as substituted) by S.I. 2021/873 Sch. 1 para. 4

  1. Introductory Text

  2. Article 1.(1) This Regulation lays down particular requirements in relation to...

  3. Article 2.For the purposes of this Regulation, the following definitions apply...

  4. Article 3.(1) Before lodging an application for a conformity assessment for...

  5. Article 4.(1) The Secretary of State must verify on a regular...

  6. Article 5.(1) Conformity assessment procedures for medical devices referred to in...

  7. Article 6.Without prejudice to Article 7(2), Member States shall take all...

  8. Article 7.(1) Holders of EC design-examination certificates or EC type-examination certificates...

  9. Article 8.Directive 2003/32/EC is repealed with effect from 29 August 2013....

  10. Article 9.This Regulation enters into force on the twentieth day following...

  11. Signature

    1. ANNEX I

      1. 1. RISK ANALYSIS AND RISK MANAGEMENT

        1. 1.1. Justification for the use of animal tissues or derivatives

        2. 1.2. Process of risk assessment

          1. 1.2.1. Animals as a source of material

          2. 1.2.2. Geographical sourcing

          3. 1.2.3. Nature of starting tissue

          4. 1.2.4. Slaughtering and processing controls to prevent cross contamination

          5. 1.2.5. Inactivation or removal of TSE infectious agents

            1. 1.2.5.1. For devices which cannot withstand an inactivation or elimination process...

            2. 1.2.5.2. For other devices, if claims are made by the manufacturer...

          6. 1.2.6. Quantities of animal tissues or derivatives required to produce one...

          7. 1.2.7. Tissues or derivatives of animal origin coming into contact with...

          8. 1.2.8. Route of administration

        3. 1.3. Review of the risk assessment

      2. 2. EVALUATION BY APPROVED BODIES

        1. 2.1. Information of the Approved Body regarding changes and new information...

        2. 2.2. Renewal of certificates

        3. 2.3. Increase of the overall TSE risk

      3. 3. RIGOROUS PROCESSES FOR TALLOW DERIVATIVES AS REFERRED TO IN ARTICLE...

    2. ANNEX II

      Details relating to the submitting approved body

      1. Details relating to the submitting notified body

        1. 1. Name of approved body

        2. 2. Approved body number

        3. 3. Country

        4. 4. Sent by

        5. 5. Contact person

        6. 6. Telephone

        7. 7. Fax

        8. 8. E-mail

        9. 9. Client reference (name of manufacturer and, if applicable, of authorised...

        10. 10. Confirmation that the submitting approved body has been designated by...

      2. Data relating to the (active implantable) medical device

        1. 11.  Active implantable medical device  Other medical device

        2. 11. Product description and composition

        3. 12. Information on intended use

        4. 13. Starting material

          1. 13. EDQM certificate available  YES  NO (If the EDQM...

          2. 13. Information regarding the nature of the starting tissue(s): animal species(s):...

        5. 14. A description of the key elements adopted to minimise the...

        6. 15. An estimate of the TSE risk arising from the use...

        7. 16. A justification for the use of animal tissues or derivatives...

        8. 17. The approach to the auditing of source establishments and suppliers...

      3. Approved Body Statement

        1. 18. Conclusion of this assessment:

      4. Date of submission

        1. 19. This report was sent on … to the Coordinating Competent...

Yn ôl i’r brig

Options/Help

Print Options

Close

Mae deddfwriaeth ar gael mewn fersiynau gwahanol:

Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.

Gwreiddiol (Fel y’i mabwysiadwyd gan yr UE): Mae'r wreiddiol version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

Dewisiadau Agor

Dewisiadau gwahanol i agor deddfwriaeth er mwyn gweld rhagor o gynnwys ar y sgrin ar yr un pryd

Close

Rhagor o Adnoddau

Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:

  • y PDF print gwreiddiol y fel adopted version that was used for the EU Official Journal
  • rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
  • pob fformat o’r holl ddogfennau cysylltiedig
  • slipiau cywiro
  • dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill
Close

Llinell Amser Newidiadau

Mae’r llinell amser yma yn dangos y fersiynau gwahanol a gymerwyd o EUR-Lex yn ogystal ag unrhyw fersiynau dilynol a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig.

Cymerir dyddiadau fersiynau’r UE o ddyddiadau’r dogfennau ar EUR-Lex ac efallai na fyddant yn cyfateb â’r adeg pan ddaeth y newidiadau i rym ar gyfer y ddogfen.

Ar gyfer unrhyw fersiynau a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig, bydd y dyddiad yn cyd-fynd â’r dyddiad cynharaf y daeth y newid (e.e. ychwanegiad, diddymiad neu gyfnewidiad) a weithredwyd i rym. Am ragor o wybodaeth gweler ein canllaw i ddeddfwriaeth ddiwygiedig ar Ddeall Deddfwriaeth.

Close

Rhagor o Adnoddau

Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:

  • y PDF print gwreiddiol y fel adopted fersiwn a ddefnyddiwyd am y copi print
  • slipiau cywiro

liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys

  • rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
  • manylion rhoi grym a newid cyffredinol
  • pob fformat o’r holl ddogfennau cysylltiedig
  • dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill